Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Crohn Disease × vedolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Crohn Disease 1

Interventions

Infliximab 2 vedolizumab 1 golimumab 1 Soybean Oil 1 Papillomavirus Vaccines 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Fish Oils 1 Calcium Dobesilate 1 CT-P13 1 Bupivacaine 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02768532 2023-06-15

VEDO-PREDIRESP

Centre Hospitalier Universitaire de Saint Etienne

Phase 4 Terminated

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡